These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 12242596)

  • 1. Fluoxetine dose and outcome in antidepressant drug trials.
    Barbui C; Hotopf M; Garattini S
    Eur J Clin Pharmacol; 2002 Sep; 58(6):379-86. PubMed ID: 12242596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Wish bias" in antidepressant drug trials?
    Barbui C; Cipriani A; Brambilla P; Hotopf M
    J Clin Psychopharmacol; 2004 Apr; 24(2):126-30. PubMed ID: 15206658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are all antidepressants really the same? The case of fluoxetine: a systematic review.
    Cipriani A; Barbui C; Brambilla P; Furukawa TA; Hotopf M; Geddes JR
    J Clin Psychiatry; 2006 Jun; 67(6):850-64. PubMed ID: 16848644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug dose as mediator of treatment effect in antidepressant drug trials: the case of fluoxetine.
    Purgato M; Gastaldon C; Papola D; Magni LR; Rossi G; Barbui C
    Acta Psychiatr Scand; 2015 Jun; 131(6):408-16. PubMed ID: 25495269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline.
    Joyce PR; Mulder RT; Luty SE; Sullivan PF; McKenzie JM; Abbott RM; Stevens IF
    Aust N Z J Psychiatry; 2002 Jun; 36(3):384-91. PubMed ID: 12060188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A test for using meta-analysis to evaluate antidepressive effects of fluoxetine].
    Jarema M
    Psychiatr Pol; 1996; 30(4):569-81. PubMed ID: 8975258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressant-benzodiazepine combination therapy.
    Furukawa T
    Am J Psychiatry; 1999 Nov; 156(11):1840. PubMed ID: 10553764
    [No Abstract]   [Full Text] [Related]  

  • 8. Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features.
    Tollefson GD; Holman SL; Sayler ME; Potvin JH
    J Clin Psychiatry; 1994 Feb; 55(2):50-9. PubMed ID: 8077155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Course of psychomotor agitation during pharmacotherapy of depression: analysis from double-blind controlled trials with fluoxetine.
    Tollefson GD; Sayler ME
    Depress Anxiety; 1996-1997; 4(6):294-311. PubMed ID: 9166658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial antidepressant choice in primary care. Effectiveness and cost of fluoxetine vs tricyclic antidepressants.
    Simon GE; VonKorff M; Heiligenstein JH; Revicki DA; Grothaus L; Katon W; Wagner EH
    JAMA; 1996 Jun; 275(24):1897-902. PubMed ID: 8648870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
    Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
    J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical depression, atypical temperament and a differential antidepressant response to fluoxetine and nortriptyline.
    Joyce PR; Mulder RT; McKenzie JM; Luty SE; Cloninger CR
    Depress Anxiety; 2004; 19(3):180-6. PubMed ID: 15129420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients.
    Versiani M; Moreno R; Ramakers-van Moorsel CJ; Schutte AJ;
    CNS Drugs; 2005; 19(2):137-46. PubMed ID: 15697327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venlafaxine: new preparation. Just another antidepressant.
    Prescrire Int; 1998 Aug; 7(36):112-4. PubMed ID: 10342950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of efficacy of l-5-hydroxytryptophan and fluoxetine in patients presenting with first depressive episode.
    Jangid P; Malik P; Singh P; Sharma M; Gulia AK
    Asian J Psychiatr; 2013 Feb; 6(1):29-34. PubMed ID: 23380314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric psychopharmacology.
    Weintrob A
    J Am Acad Child Adolesc Psychiatry; 2000 Apr; 39(4):397-8. PubMed ID: 10761337
    [No Abstract]   [Full Text] [Related]  

  • 17. Effectiveness of fluoxetine and doxepin in treatment of melancholia in depressed patients.
    Sandor P; Baker B; Irvine J; Dorian P; McKessok D; Mendlowitz S
    Depress Anxiety; 1998; 7(2):69-72. PubMed ID: 9614594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fluoxetine and tricyclic antidepressants: clinical tolerance in short-term combined administration].
    Bonin B; Bertschy G; Baumann P; Francois T; Vandel P; Vandel S; Sechter D; Bizouard P
    Encephale; 1996; 22(3):221-7. PubMed ID: 8767051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and mood conversion rate of short-term fluoxetine monotherapy in patients with rapid cycling bipolar II depression versus patients with nonrapid cycling bipolar II depression.
    Amsterdam JD; Luo L; Shults J
    J Clin Psychopharmacol; 2013 Jun; 33(3):420-4. PubMed ID: 23609385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoxetine and imipramine: are there differences in cost-utility for depression in primary care?
    Serrano-Blanco A; Suárez D; Pinto-Meza A; Peñarrubia MT; Haro JM;
    J Eval Clin Pract; 2009 Feb; 15(1):195-203. PubMed ID: 19239602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.